LTCCF yields 3372.68% · PFE yields 6.20%● Live data
📍 LTCCF pulled ahead of the other in Year 1
Combined, LTCCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LTCCF + PFE for your $10,000?
Lite Access Technologies Inc. manufactures, distributes, sells, and installs fiber optic technology specializing in micro-duct and air-blown fiber in Canada, the United States, and internationally. It operates through three segments: Product, Fibre Optic Installation, and Concrete Cutting. The company offers micro-duct, air-blown fiber, and micro and narrow trench installation services for use in various communication networks. It also provides fiber-optic cables, aerial and low fire hazard micro-ducts, connectors, and sundries, as well as proprietary items, such as a cutting head, shark blades, and the LiteXtend solution, as well as breeze cable blowing machines. The company serves municipal and regional governments, telecom carriers and internet service providers, first nations communities, and fibre to the home/premises, as well as intelligent traffic control, healthcare, point to point, and education networks. Lite Access Technologies Inc. was incorporated in 2003 and is headquartered in Langley, Canada.
Full LTCCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.